The Effect of an Oral Medicine on Nausea and Vomiting Caused by Chemotherapy in Children With Cancer.
Phase 3
Recruiting
- Conditions
- ausea and vomiting.Nausea and vomiting
- Registration Number
- IRCT20150119020715N6
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Children aged 5 to 15 years of age who have recently diagnosed as malignancy
Indication of chemotherapy, based on assessment, diagnosis and approval by physician
On the first day of chemotherapy, they should have a RAS score more than 20.
Exclusion Criteria
Diseases that triggers the nausea and vomiting
Inability to express the severity of nausea and vomiting
Patients who has not satisfied with the study
Olanzapine drug complications
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea and vomiting. Timepoint: Before starting chemotherapy, 24 hours after chemotherapy and 5 days after chemotherapy. Method of measurement: To evaluate the state of nausea and vomiting in patients, RAS criteria will be used to measure the state of nausea and vomiting in patients from 1 to 100.
- Secondary Outcome Measures
Name Time Method